| Tamoxifen studied in …STUDIED_INderived200 of 306show all (up to 200) |
|---|
| → studied in | NCT04906395Phase 3 · active not recruiting Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06075953Phase 2 · recruiting DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment · 306 trials list this drug (56 active) | — | — | Intraductal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06979596Phase 2 · recruiting A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015) · 306 trials list this drug (56 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04570956Phase 2 · terminated Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · 306 trials list this drug (56 active) | — | — | Breast Atypical Hyperplasia,Breast Atypical Lobular Hyperplasia,Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06179303Phase 2 · recruiting Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | HER2-Negative Breast Carcinoma,Hormone Receptor-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06440967Phase 3 · active not recruiting A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287098Phase 2 · recruiting A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05161195Phase 4 · active not recruiting Roll-over Study to Allow Continued Access to Ribociclib · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05512364Phase 3 · recruiting Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06492616Phase 3 · recruiting A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06033092Phase 2 · completed Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion · 306 trials list this drug (56 active) | — | — | Breast Lobular Carcinoma In Situ,Intraductal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00310180Phase 3 · active not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Breast Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07806630Phase 2 · active not recruiting SHORTened Duration of TAMoxifen · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06671912Phase 3 · suspended Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial · 306 trials list this drug (56 active) | — | — | Breast Lobular Carcinoma In Situ,Breast Ductal Carcinoma In Situ,HER2-Negative Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05645536Phase 3 · enrolling by invitation Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05150652Phase 2 · completed Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601900Phase 3 · completed Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01272037Phase 3 · active not recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Carcinoma,Breast Ductal Carcinoma In Situ,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311933Phase 2 · active not recruiting Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066690Phase 3 · completed Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05035836Phase 2 · recruiting A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05501704Phase 2 · recruiting ETHAN - ET for Male BC · 306 trials list this drug (56 active) | — | — | Male Breast Carcinoma,Hormone Receptor-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05774951Phase 3 · recruiting A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762885Phase 3 · recruiting Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery · 306 trials list this drug (56 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05952557Phase 3 · active not recruiting An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02206984Phase 2 · completed Endocrine Response in Women With Invasive Lobular Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101788Phase 2/Phase 3 · completed Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer · 306 trials list this drug (56 active) | — | — | Borderline Ovarian Serous Tumor,Micropapillary Serous Carcinoma,Ovarian Serous Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06195306Phase 2 · recruiting Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction · 306 trials list this drug (56 active) | — | — | Breast Atypical Hyperplasia,Breast Carcinoma,Breast Lobular Carcinoma In Situ+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02476786Phase 2 · recruiting Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06184750Phase 2 · recruiting Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial · 306 trials list this drug (56 active) | — | — | Breast Atypical Lobular Hyperplasia,Breast Carcinoma,Breast Lobular Carcinoma In Situ+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04174352early Phase 1 · recruiting FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942039early Phase 1 · recruiting Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation · 306 trials list this drug (56 active) | — | — | Central Nervous System Embryonal Tumor,Atypical Teratoid/Rhabdoid Tumor,Central Nervous System Embryonal Tumor with Rhabdoid Features+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05768139Phase 1/Phase 2 · recruiting First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors · 306 trials list this drug (56 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941520Phase 2 · recruiting Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Atypical Hyperplasia,Breast Carcinoma,Breast Lobular Carcinoma In Situ+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001762Phase 2 · active not recruiting TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02764541Phase 2 · active not recruiting Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05306340Phase 3 · active not recruiting A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07535905Phase 2 · not yet recruiting Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients · 306 trials list this drug (56 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03011684Phase 3 · recruiting Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349069Phase 3 · recruiting A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06320990Phase 1 · recruiting Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection · 306 trials list this drug (56 active) | — | — | Pancreatic Mucinous Cystic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06630325Phase 2 · terminated A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer · 306 trials list this drug (56 active) | — | — | Malignant Solid Neoplasm,Sarcoma,Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05982093Phase 2 · recruiting Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06434064Phase 2 · recruiting Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01027416NA · completed Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01553903Phase 4 · completed Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05514054Phase 3 · active not recruiting A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07499999Phase 2 · not yet recruiting Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Atypical Lobular Hyperplasia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05659563Phase 2 · completed Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00893061Phase 3 · completed Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06982313completed Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04059484Phase 2 · terminated Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003042Phase 2 · completed Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06348134Phase 2 · recruiting Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04504331Phase 1 · terminated Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05101564Phase 2 · completed Umbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674140Phase 3 · active not recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066703Phase 3 · completed Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02747004Phase 2 · active not recruiting A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057133Phase 1 · active not recruiting A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03879577Phase 2 · active not recruiting Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02668666Phase 2 · completed Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01196936Phase 2 · active not recruiting Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364267Phase 2 · recruiting Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer. · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03280563Phase 1/Phase 2 · completed A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05128773Phase 3 · terminated Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07145827NA · completed Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04300790Phase 2 · completed Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04765098Phase 2 · recruiting Tamoxifen Versus Etoposide After First Recurrence in GBM Patients · 306 trials list this drug (56 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03554044Phase 1 · completed T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Carcinoma,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05156892Phase 1 · active not recruiting Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer · 306 trials list this drug (56 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03219476Phase 2 · completed Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03161353Phase 2 · active not recruiting Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06223698Phase 3 · not yet recruiting Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914674Phase 2 · recruiting Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas · 306 trials list this drug (56 active) | — | — | Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03346200Phase 2 · completed Low Dose Tamoxifen for Mammographic Density Reduction · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03691493Phase 2 · completed Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis · 306 trials list this drug (56 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00667121completed Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00949598Phase 3 · completed Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079517Phase 1/Phase 2 · completed Karolinska Interventional Study of Mammograhic Density (Karisma-1) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02993159Phase 2 · completed Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast · 306 trials list this drug (56 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985266Phase 2 · recruiting A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02913430early Phase 1 · completed Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072462Phase 3 · completed Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02228681Phase 2 · completed Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04129216Phase 2 · completed The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03870399Phase 2 · completed Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression · 306 trials list this drug (56 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03272477Phase 2 · completed Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06355401Phase 2/Phase 3 · not yet recruiting Maintenance Hormonal Therapy and DLBCL · 306 trials list this drug (56 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06346457unknown Breast Cancer & Antiestrogenic Therapy & Brain · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03423199Phase 3 · unknown PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295646Phase 3 · completed Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278120Phase 3 · completed Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424164Phase 1 · completed Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891093Phase 3 · recruiting Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04961632Phase 1 · unknown Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376 · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05525481Phase 4 · unknown Tamoxifen Prediction Study in Patients With ER+ Breast Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499083Phase 2 · completed Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298713Phase 2 · completed Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584465Phase 2 · completed REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression · 306 trials list this drug (56 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04190056Phase 2 · terminated Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01357772Phase 3 · active not recruiting Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309478Phase 3 · completed Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients · 306 trials list this drug (56 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01124695Phase 2 · completed Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01579734Phase 3 · unknown Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004125Phase 3 · completed Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03917082Phase 2 · active not recruiting Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333370Phase 1 · completed A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05801705unknown Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800197unknown Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412022Phase 3 · unknown HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02914158Phase 3 · unknown Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433589Phase 3 · completed Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02285179Phase 1/Phase 2 · completed Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05501158NA · unknown CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003857Phase 3 · completed Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05133674Phase 2 · unknown Therapeutic Dose Monitoring (TDM) of Tamoxifen · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02062489Phase 3 · unknown Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666961Phase 2 · recruiting Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ · 306 trials list this drug (56 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269670Phase 2 · terminated Phase II Study of Everolimus Beyond Progression · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02384239Phase 2 · completed A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00710970Phase 2 · completed Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment · 306 trials list this drug (56 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02586675Phase 1 · completed TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05131893not yet recruiting Neoadjuvant Treatment of Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02988986Phase 2 · completed TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05016349Phase 3 · unknown Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02936206Phase 1 · terminated Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant. · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852081unknown Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01220076Phase 2 · completed Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00738777Phase 2 · suspended Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02197897Phase 2 · completed Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors · 306 trials list this drug (56 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666805unknown Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290745Phase 1/Phase 2 · completed Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192308Phase 1 · completed PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006388Phase 2 · completed Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005970Phase 3 · completed Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Breast Adenocarcinoma,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02395627Phase 2 · terminated Reversing Therapy Resistance With Epigenetic-Immune Modification · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04389424unknown Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002542Phase 3 · completed Tamoxifen in Treating Women With High-Risk Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002864Phase 3 · completed Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003032Phase 3 · completed High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01393990Phase 1 · completed A Study of LY2228820 in Participants With Advanced Cancer · 306 trials list this drug (56 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02866955Phase 2 · completed Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor. · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758146Phase 3 · unknown Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068419Phase 2 · completed Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor · 306 trials list this drug (56 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02291913Phase 2 · completed Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541086Phase 3 · unknown Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116827unknown Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02093351Phase 1 · completed To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer · 306 trials list this drug (56 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344940Phase 4 · completed Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03024580Phase 2 · unknown A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04046159Phase 3 · unknown Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ · 306 trials list this drug (56 active) | — | — | Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00041080Phase 3 · completed Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · 306 trials list this drug (56 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00729586Phase 2 · completed Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer · 306 trials list this drug (56 active) | — | — | Endometrial Carcinoma,Endometrial Neoplasm,Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02970682Phase 2 · completed SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582865unknown Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02995772Phase 3 · completed Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03925233unknown Breast Cancer Treatment Based on Organ-like Culture · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03058939Phase 2 · withdrawn Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01685255Phase 2 · terminated A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy · 306 trials list this drug (56 active) | — | — | Ovarian Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03715413Phase 2 · completed Analgesic Efficacy of Pulsed Radiofrequency in Non-cyclic Mastalgia · 306 trials list this drug (56 active) | — | — | Breast Fibroadenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096369Phase 2 · terminated Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03238703Phase 4 · withdrawn Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03137368Phase 3 · unknown A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP） · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053898Phase 3 · completed Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638247Phase 3 · completed Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients · 306 trials list this drug (56 active) | — | — | Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00687102Phase 3 · completed Cognition in the Study of Tamoxifen and Raloxifene · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614210Phase 2 · completed Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00728949Phase 2 · completed A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02404844Phase 2 · completed Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00847366NA · completed Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma · 306 trials list this drug (56 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Sarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00194779Phase 2 · completed Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873366terminated Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290654Phase 2 · terminated Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03373708Phase 2/Phase 3 · unknown Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004205Phase 3 · completed Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118157Phase 2 · completed Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03351062Phase 3 · unknown Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00590785Phase 3 · completed Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00900744completed A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6 · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00206492Phase 2 · terminated Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00764322Phase 2 · completed Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00899197terminated Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003199Phase 2 · completed Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma,Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03211572Phase 2 · unknown The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02322853Phase 2 · terminated A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02513849Phase 1 · unknown Tamoxifen in Patients With Oesophageal Cancer · 306 trials list this drug (56 active) | — | — | Digestive System Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02467686Phase 4 · unknown Breast Cancer, Sexuality and Black Cohosh · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02089386early Phase 1 · terminated Tamoxifen to Treat Barrett's Metaplasia · 306 trials list this drug (56 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171704Phase 3 · completed A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer · 306 trials list this drug (56 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02806544Phase 2 · completed Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country · 306 trials list this drug (56 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005886Phase 1 · completed Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066807Phase 3 · terminated Premenopausal Endocrine Responsive Chemotherapy Trial · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00293540Phase 3 · completed Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659373Phase 3 · completed Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031720Phase 2 · completed Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00053339Phase 3 · withdrawn Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01293032NA · completed Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm,Breast Lobular Carcinoma In Situ,Breast Ductal Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896050completed Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02097459Phase 3 · unknown Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer · 306 trials list this drug (56 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |